Local administration of various cytostatic drugs after subcutaneous immunization enhances delayed-type hypersensitivity reaction to sheep red blood cells in mice

Scand J Immunol. 1986 May;23(5):605-9. doi: 10.1111/j.1365-3083.1986.tb01994.x.

Abstract

Delayed hypersensitivity reaction in mice was enhanced with various anti-cancer drugs administered at the site of antigenic stimulation during 4 days following sensitization. The immunopotentiating effect of the presented local chemotherapy protocol is thought to result from impairment of a regulatory circuit, with activated suppressor T cells (Ts) as target rather than Ts precursors or Ts-inducing antigen-presenting cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Cell Cycle / drug effects
  • Cisplatin / pharmacology
  • Cyclophosphamide / analogs & derivatives
  • Cyclophosphamide / pharmacology
  • Dose-Response Relationship, Drug
  • Doxorubicin / pharmacology
  • Erythrocytes / immunology
  • Etoposide / pharmacology
  • Hypersensitivity, Delayed / immunology*
  • Immunity, Cellular / drug effects*
  • Male
  • Mice
  • Mice, Inbred DBA
  • Sheep
  • T-Lymphocytes, Regulatory / drug effects
  • Time Factors
  • Vincristine / pharmacology

Substances

  • Antineoplastic Agents
  • Vincristine
  • Etoposide
  • Doxorubicin
  • Asta Z 7557
  • Cyclophosphamide
  • Cisplatin